AKT1 and glioma: Hence, unravelling the multi-faceted interactions between ROS metabolism and PI3K/AKT/mTOR, paving a way out for apoptosis will undoubtedly provide novel insights on the identification of exploitable vulnerabilities for treatment of hyperactive PI3K/AKT/mTOR tumors like glioma.